Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Lowry

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Annals of Surgery|July 1, 1994
Anti-endotoxin therapy in primate bacteremia with HA-1A and BPIM A Rogy, L L Moldawer, H S Oldenburg, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1990
Harry M. Vars award. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxinA E Barber, W G Jones, J P Minei, et al.
Circulatory Shock|September 1, 1994
Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsisC J Fisher, S M Opal, S F Lowry, et al.
Blood|August 1, 1996
Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptorT van der Poll, P M Jansen, K J Van Zee, et al.
The Journal of Experimental Medicine|March 17, 1997
Epinephrine exerts anticoagulant effects during human endotoxemiaT van der Poll, M Levi, M Dentener, et al.
Infection and Immunity|September 1, 1995
Effect of hypertriglyceridemia on endotoxin responsiveness in humansT van der Poll, C C Braxton, S M Coyle, et al.
Critical Care Medicine|June 2, 2000
Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemiaS R Grobmyer, P S Barie, C F Nathan, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1994
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsisS E Calvano, W A Thompson, M N Marra, et al.
The Journal of Infectious Diseases|August 1, 1995
Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsisT van der Poll, E Fischer, S M Coyle, et al.
Blood|May 15, 1997
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humansT van der Poll, S M Coyle, M Levi, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Annals of Surgery|July 1, 1994
Anti-endotoxin therapy in primate bacteremia with HA-1A and BPIM A Rogy, L L Moldawer, H S Oldenburg, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1990
Harry M. Vars award. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxinA E Barber, W G Jones, J P Minei, et al.
Circulatory Shock|September 1, 1994
Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsisC J Fisher, S M Opal, S F Lowry, et al.
Blood|August 1, 1996
Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptorT van der Poll, P M Jansen, K J Van Zee, et al.
The Journal of Experimental Medicine|March 17, 1997
Epinephrine exerts anticoagulant effects during human endotoxemiaT van der Poll, M Levi, M Dentener, et al.
Infection and Immunity|September 1, 1995
Effect of hypertriglyceridemia on endotoxin responsiveness in humansT van der Poll, C C Braxton, S M Coyle, et al.
Critical Care Medicine|June 2, 2000
Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemiaS R Grobmyer, P S Barie, C F Nathan, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1994
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsisS E Calvano, W A Thompson, M N Marra, et al.
The Journal of Infectious Diseases|August 1, 1995
Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsisT van der Poll, E Fischer, S M Coyle, et al.
Blood|May 15, 1997
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humansT van der Poll, S M Coyle, M Levi, et al.
Pageof 20